Does 2019-nCoV matter for markets?
The coronavirus has added uncertainty to an otherwise low-volatility market environment. Recent developments suggest that the spread of the virus can be contained.
Global financial markets have reacted strongly to rising concerns over the spread of a novel coronavirus. After starting the year on a positive note, most risky assets took a dive at the end of January when the outbreak intensified, though most of this correction has now been recovered.
In the near term, we expect more volatility as a result, but ultimately, we see this as a temporary phenomenon that should only marginally affect global economic growth and markets.
Going back more than 20 years, Kieger’s legacy has been built in healthcare and small companies. Over these decades we have developed our own “unique” asset allocation which has some outstanding and attractive portfolio characteristics, especially in recent turbulent times.
One month ago, markets finally took note of COVID-19 and its critical impact on the global economy. Our Healthcare Investment Team recently published a “Thoughts from the street” piece that provides more details about SARSCoV- 2 treatment developments.